Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Effect of Redox Potential on Diiron-Mediated Disproportionation of Hydrogen Peroxide.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: PubMed not MEDLINE; MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI, c1995-
    • نبذة مختصرة :
      Heme and nonheme dimanganese catalases are widely distributed in living organisms to participate in antioxidant defenses that protect biological systems from oxidative stress. The key step in these processes is the disproportionation of H 2 O 2 to O 2 and water, which can be interpreted via two different mechanisms, namely via the formation of high-valent oxoiron(IV) and peroxodimanganese(III) or diiron(III) intermediates. In order to better understand the mechanism of this important process, we have chosen such synthetic model compounds that can be used to map the nature of the catalytically active species and the factors influencing their activities. Our previously reported μ -1,2-peroxo-diiron(III)-containing biomimics are good candidates, as both proposed reactive intermediates (Fe IV O and Fe III2 ( μ -O 2 )) can be derived from them. Based on this, we have investigated and compared five heterobidentate-ligand-containing model systems including the previously reported and fully characterized [Fe II (L 1-4 ) 3 ] 2+ (L 1 = 2-(2'-pyridyl)-1 H -benzimidazole, L 2 = 2-(2'-pyridyl)- N -methyl-benzimidazole, L 3 = 2-(4-thiazolyl)-1 H -benzimidazole and L 4 = 2-(4'-methyl-2'-pyridyl)-1 H -benzimidazole) and the novel [Fe II (L 5 ) 3 ] 2+ (L 5 = 2-(1 H -1,2,4-triazol-3-yl)-pyridine) precursor complexes with their spectroscopically characterized μ -1,2-peroxo-diiron(III) intermediates. Based on the reaction kinetic measurements and previous computational studies, it can be said that the disproportionation reaction of H 2 O 2 can be interpreted through the formation of an electrophilic oxoiron(IV) intermediate that can be derived from the homolysis of the O-O bond of the forming μ -1,2-peroxo-diiron(III) complexes. We also found that the disproportionation rate of the H 2 O 2 shows a linear correlation with the Fe III/ Fe II redox potential (in the range of 804 mV-1039 mV vs. SCE) of the catalysts controlled by the modification of the ligand environment. Furthermore, it is important to note that the two most active catalysts with L 3 and L 5 ligands have a high-spin electronic configuration.
    • References:
      Chem Rev. 2004 Feb;104(2):903-38. (PMID: 14871145)
      J Biol Chem. 2010 Dec 10;285(50):38933-43. (PMID: 20923778)
      Inorg Chem. 1999 Mar 22;38(6):1085-1092. (PMID: 11670888)
      Chem Commun (Camb). 2014 Feb 9;50(11):1326-9. (PMID: 24343416)
      Molecules. 2023 Feb 15;28(4):. (PMID: 36838842)
      Arch Biochem Biophys. 2012 Sep 15;525(2):111-20. (PMID: 22198285)
      Structure. 2001 Aug;9(8):725-38. (PMID: 11587647)
      Dalton Trans. 2021 Jun 1;50(21):7181-7185. (PMID: 34019062)
      Basic Life Sci. 1988;49:651-61. (PMID: 3074793)
      Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78. (PMID: 16490224)
      Molecules. 2021 Jul 26;26(15):. (PMID: 34361652)
      Free Radic Biol Med. 2015 Sep;86:308-21. (PMID: 26026699)
      Molecules. 2019 Sep 05;24(18):. (PMID: 31491998)
      Chemistry. 2019 Nov 13;25(63):14290-14294. (PMID: 31448834)
      Dalton Trans. 2020 Feb 11;49(6):1742-1746. (PMID: 31967142)
      Redox Biol. 2015 Aug;5:43-65. (PMID: 25827425)
      Biochemistry. 1997 Aug 5;36(31):9356-64. (PMID: 9235978)
      Arch Biochem Biophys. 2012 Sep 15;525(2):131-44. (PMID: 22330759)
      Annu Rev Microbiol. 2003;57:395-418. (PMID: 14527285)
      Dalton Trans. 2016 Oct 7;45(37):14709-18. (PMID: 27283752)
      Antioxid Redox Signal. 2005 May-Jun;7(5-6):685-93. (PMID: 15890013)
      Free Radic Biol Med. 2016 Apr;93:118-29. (PMID: 26826576)
      J Biol Chem. 1983 May 25;258(10):6015-9. (PMID: 6853475)
      Front Microbiol. 2016 Nov 18;7:1822. (PMID: 27917155)
      Saudi Med J. 2000 Sep;21(9):826-30. (PMID: 11376358)
      Proc Natl Acad Sci U S A. 1990 Jan;87(1):384-8. (PMID: 2296593)
      Diabetes. 1997 Nov;46(11):1733-42. (PMID: 9356019)
      Free Radic Biol Med. 1997;23(1):134-47. (PMID: 9165306)
      J Bacteriol. 2002 Jun;184(12):3305-12. (PMID: 12029047)
      Clin Chim Acta. 1992 Apr 30;207(1-2):155-8. (PMID: 1591863)
      Antioxid Redox Signal. 2008 Sep;10(9):1527-48. (PMID: 18498226)
      Eur J Inorg Chem. 2013 Aug;2013(22-23):3858-3866. (PMID: 24587695)
      Microbiol Rev. 1991 Dec;55(4):561-85. (PMID: 1779927)
      Acta Crystallogr D Biol Crystallogr. 1999 Aug;55(Pt 8):1383-94. (PMID: 10417406)
      Hum Genet. 1991 Feb;86(4):331-40. (PMID: 1999334)
      J Am Chem Soc. 2013 May 1;135(17):6438-41. (PMID: 23594282)
      Inorg Chem. 2013 Aug 19;52(16):9229-44. (PMID: 23901826)
      Annu Rev Microbiol. 2009;63:575-97. (PMID: 19575568)
      Inorg Chem. 2005 Oct 31;44(22):8125-34. (PMID: 16241163)
      Arch Biochem Biophys. 1986 May 1;246(2):501-14. (PMID: 3010861)
      J Bacteriol. 1986 Nov;168(2):563-7. (PMID: 3782016)
    • Contributed Indexing:
      Keywords: catalase-like activity; kinetics; nonheme models; μ-1,2-peroxo-diiron(III) intermediates
    • الموضوع:
      Date Created: 20230413 Date Completed: 20230413 Latest Revision: 20230415
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC10096046
    • الرقم المعرف:
      10.3390/molecules28072905
    • الرقم المعرف:
      37049667